168 related articles for article (PubMed ID: 27527159)
1. Gene Set-Based Integrative Analysis Revealing Two Distinct Functional Regulation Patterns in Four Common Subtypes of Epithelial Ovarian Cancer.
Chang CM; Chuang CM; Wang ML; Yang YP; Chuang JH; Yang MJ; Yen MS; Chiou SH; Chang CC
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527159
[TBL] [Abstract][Full Text] [Related]
2. Gene Set-Based Functionome Analysis of Pathogenesis in Epithelial Ovarian Serous Carcinoma and the Molecular Features in Different FIGO Stages.
Chang CM; Chuang CM; Wang ML; Yang MJ; Chang CC; Yen MS; Chiou SH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275818
[TBL] [Abstract][Full Text] [Related]
3. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
4. Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.
Yoffou PH; Edjekouane L; Meunier L; Tremblay A; Provencher DM; Mes-Masson AM; Carmona E
PLoS One; 2011; 6(6):e20705. PubMed ID: 21695196
[TBL] [Abstract][Full Text] [Related]
5. Genes with bimodal expression are robust diagnostic targets that define distinct subtypes of epithelial ovarian cancer with different overall survival.
Kernagis DN; Hall AH; Datto MB
J Mol Diagn; 2012; 14(3):214-22. PubMed ID: 22490445
[TBL] [Abstract][Full Text] [Related]
6. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
[TBL] [Abstract][Full Text] [Related]
7. An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response.
Pinciroli P; Alberti C; Sensi M; Canevari S; Tomassetti A
BMC Genomics; 2013 Jul; 14():508. PubMed ID: 23889749
[TBL] [Abstract][Full Text] [Related]
8. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
[TBL] [Abstract][Full Text] [Related]
9. Gene set-based analysis of mucinous ovarian carcinoma.
Chang CM; Wang PH; Horng HC
Taiwan J Obstet Gynecol; 2017 Apr; 56(2):210-216. PubMed ID: 28420510
[TBL] [Abstract][Full Text] [Related]
10. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
11. NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis.
Chen C; Hu Y; Li L
Mol Med Rep; 2016 Jan; 13(1):188-96. PubMed ID: 26573160
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
Zhang M; Luo SC
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative Diagnosis Support Tool for Serous Ovarian Tumors Based on Microarray Data Using Multicategory Machine Learning.
Park JS; Choi SB; Kim HJ; Cho NH; Kim SW; Kim YT; Nam EJ; Chung JW; Kim DW
Int J Gynecol Cancer; 2016 Jan; 26(1):104-13. PubMed ID: 26512784
[TBL] [Abstract][Full Text] [Related]
14. Efficient molecular subtype classification of high-grade serous ovarian cancer.
Leong HS; Galletta L; Etemadmoghadam D; George J; ; Köbel M; Ramus SJ; Bowtell D
J Pathol; 2015 Jul; 236(3):272-7. PubMed ID: 25810134
[TBL] [Abstract][Full Text] [Related]
15. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
16. Exploration of the sequential gene changes in epithelial ovarian cancer induced by carboplatin via microarray analysis.
Wei S; Liu J; Shi Y; Zhang X; Yang Y; Song Q
Mol Med Rep; 2017 Sep; 16(3):3155-3160. PubMed ID: 28713952
[TBL] [Abstract][Full Text] [Related]
17. Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes.
Earp MA; Raghavan R; Li Q; Dai J; Winham SJ; Cunningham JM; Natanzon Y; Kalli KR; Hou X; Weroha SJ; Haluska P; Lawrenson K; Gayther SA; Wang C; Goode EL; Fridley BL
Oncotarget; 2017 Jul; 8(29):46891-46899. PubMed ID: 28423358
[TBL] [Abstract][Full Text] [Related]
18. Key Immunological Functions Involved in the Progression of Epithelial Ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome Analysis.
Chang CC; Su KM; Lu KH; Lin CK; Wang PH; Li HY; Wang ML; Lin CK; Yu MH; Chang CM
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30356023
[TBL] [Abstract][Full Text] [Related]
19. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.
Cuellar-Partida G; Lu Y; Dixon SC; ; Fasching PA; Hein A; Burghaus S; Beckmann MW; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Vanderstichele A; Doherty JA; Rossing MA; Chang-Claude J; Rudolph A; Wang-Gohrke S; Goodman MT; Bogdanova N; Dörk T; Dürst M; Hillemanns P; Runnebaum IB; Antonenkova N; Butzow R; Leminen A; Nevanlinna H; Pelttari LM; Edwards RP; Kelley JL; Modugno F; Moysich KB; Ness RB; Cannioto R; Høgdall E; Høgdall C; Jensen A; Giles GG; Bruinsma F; Kjaer SK; Hildebrandt MA; Liang D; Lu KH; Wu X; Bisogna M; Dao F; Levine DA; Cramer DW; Terry KL; Tworoger SS; Stampfer M; Missmer S; Bjorge L; Salvesen HB; Kopperud RK; Bischof K; Aben KK; Kiemeney LA; Massuger LF; Brooks-Wilson A; Olson SH; McGuire V; Rothstein JH; Sieh W; Whittemore AS; Cook LS; Le ND; Blake Gilks C; Gronwald J; Jakubowska A; Lubiński J; Kluz T; Song H; Tyrer JP; Wentzensen N; Brinton L; Trabert B; Lissowska J; McLaughlin JR; Narod SA; Phelan C; Anton-Culver H; Ziogas A; Eccles D; Campbell I; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Wu AH; Dansonka-Mieszkowska A; Kupryjanczyk J; Timorek A; Szafron L; Cunningham JM; Fridley BL; Winham SJ; Bandera EV; Poole EM; Morgan TK; Goode EL; Schildkraut JM; Pearce CL; Berchuck A; Pharoah PD; Webb PM; Chenevix-Trench G; Risch HA; MacGregor S
Hum Genet; 2016 Jul; 135(7):741-56. PubMed ID: 27075448
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics.
Chang CM; Li YF; Lin HC; Lu KH; Lin TW; Liu LC; Su KM; Chang CC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
